Steven joins Circle Pharma with over 13 year’s experience working on early stage formulation development. Prior to joining Circle Pharma, Steven spent over seven years developing and supporting pre-clinical PK/efficacy formulations for all oncology discovery programs at Abbvie/Legacy Pharmacyclics. Steven contributed heavily to the formulation and tech transfer for pediatric oral Imbruvica. Steven holds a B.S. in Integrative Biology from UC Berkeley.